Celgene Corp. has appointed John Weiland as a director.
Weiland most recently served as the COO and president of C. R. Bard Inc. prior to it being acquired by Becton Dickinson and Co.
Celgene adds board member
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Celgene Corp. has appointed John Weiland as a director.
Weiland most recently served as the COO and president of C. R. Bard Inc. prior to it being acquired by Becton Dickinson and Co.